Should I Buy NRIM? NRIM 2026 Analysis

Should You Buy Northrim BanCorp Inc (NRIM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

25.850

1 Day change

2.05%

52 Week Range

30.820

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: recent earnings miss + fresh legal investigation headline has shifted near-term sentiment negative.
Price is sitting near the pivot (~~25.17) with no strong bullish technical trigger; downside risk remains toward S1 (~~22.56) if support fails.
With no Intellectia buy signals today and only modest statistical upside over the next week/month, this does not fit an impatient “buy now” setup.
Prefer to avoid new entries until the stock reclaims strength (e.g., stabilizes and starts pushing back toward ~27.78 resistance).

Technical Analysis

Trend/Momentum: MACD histogram is negative (-0.165) but contracting, implying bearish momentum is easing—not reversing.
RSI (6): ~50.76 (neutral), indicating no clear oversold bounce signal.
Moving averages: converging, consistent with a transition phase rather than a confirmed uptrend.
Key levels: Pivot 25.167 (price ~25.2 is basically on it). Resistance R1 27.775; Support S1 22.559 (next meaningful downside area).
Pattern-based forward bias: ~70% chance of small gains (next day ~+0.27%, next week ~+2.48%), but weak follow-through expectation (next month ~+0.72%).

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- 2025/Q4 fundamentals show YoY growth: revenue, net income, and EPS all increased.
- Bearish momentum is easing (MACD negative but contracting), which can sometimes precede stabilization if news flow calms.

Neutral/Negative Catalysts

- 2025/Q4 EPS miss vs expectations and the stock already reacted sharply (post-earnings drawdown).
- Pomerantz LLP investigation headline introduces ongoing overhang and can suppress near-term bids.
- No strong institutional/insider accumulation signals: hedge funds neutral; insiders neutral.

Financial Performance

Latest quarter: 2025/Q4.
Revenue: 43,756,000 (+9.71% YoY).
Net income: 12,441,000 (+13.86% YoY).
EPS: 0.55 (+12.24% YoY).
Takeaway: operating results are growing YoY, but the market is currently prioritizing the earnings miss and negative event headlines.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price-target change data was provided, so a clear Wall Street “pros vs cons” consensus cannot be confirmed from this dataset.
Practical read-through from available info: fundamentals are improving (a pro), but the earnings miss and investigation headline are dominating near-term perception (a con).

Analyst Rating

Wall Street analysts forecast NRIM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NRIM is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 25.330

Low

Averages

High